In Vitro Antiviral Screening Program
体外抗病毒筛查计划
基本信息
- 批准号:8327428
- 负责人:
- 金额:$ 2.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-09 至 2011-08-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The In Vitro Antiviral Screening Program provides in vitro screening systems to evaluate experimental antiviral substances.
体外抗病毒筛选计划提供体外筛选系统,以评估实验性抗病毒物质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donald F. Smee其他文献
O1 - Computationally engineered influenza antiviral affords broad prophylactic and therapeutic protection against influenza
- DOI:
10.1016/s2055-6640(20)31112-2 - 发表时间:
2016-05-01 - 期刊:
- 影响因子:
- 作者:
Deborah Heydenburg Fuller;Merika Treants Koday;Jorgen Nelson;Aaron Chevalier;Michael Koday;Donald F. Smee;Amy L. Hartman;Douglas S. Reed;Kelly Stefano Cole;David Baker - 通讯作者:
David Baker
Favipiravir (T-705) Treatment of Experimental Arenaviral Infection Initiated after the Onset of Clinical Disease
- DOI:
10.1016/j.antiviral.2011.03.093 - 发表时间:
2011-05-01 - 期刊:
- 影响因子:
- 作者:
Brian B. Gowen;Michelle Mendenhall;Andrew Russell;Donald F. Smee;Yousuke Furuta - 通讯作者:
Yousuke Furuta
Induction of Interferon Gamma Inducible Protein 10 by SARS-CoV Infection, Interferon Alfacon 1 and Interferon Inducer in Human Bronchial Epithelial Calu-3 Cells and BALB/c Mice
- DOI:
10.1016/j.antiviral.2009.02.064 - 发表时间:
2009-05-01 - 期刊:
- 影响因子:
- 作者:
Yohichi Kumaki;Craig W. Day;Miles K. Wandersee;Jason R. Madsen;John D. Woolcott;Justin D. Hoopes;Kevin W. Bailey;Min-Hui Wong;Donald F. Smee;John D. Morrey;Dale L. Barnard - 通讯作者:
Dale L. Barnard
Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication in a Lethal SARS-Cov Balb/C Mouse Model by Stinging Nettle Lectin, Urtica Dioica Agglutinin (UDA)
- DOI:
10.1016/j.antiviral.2010.02.382 - 发表时间:
2010-04-01 - 期刊:
- 影响因子:
- 作者:
Yohichi Kumaki;Miles K. Wandersee;Kevin W. Bailey;Aaron J. Smith;Craig W. Day;Jason R. Madson;Donald F. Smee;Dale L. Barnard - 通讯作者:
Dale L. Barnard
Activity of Isatine-sulphadimidine Derivatives Against 2009 Pandemic H1N1 Influenza Virus in Cell Culture
- DOI:
10.1016/j.antiviral.2010.02.407 - 发表时间:
2010-04-01 - 期刊:
- 影响因子:
- 作者:
Periyasamy Selvam;Markandavel Chandramohan;Brett L. Hurst;Donald F. Smee - 通讯作者:
Donald F. Smee
Donald F. Smee的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donald F. Smee', 18)}}的其他基金
IN VITRO ANTIVIRAL SCREENING PROGRAM- RESPIRATORY VIRUSES AND BIO DEFENSE PATHOG
体外抗病毒筛查计划 - 呼吸道病毒和生物防御病原体
- 批准号:
7543731 - 财政年份:2003
- 资助金额:
$ 2.5万 - 项目类别:
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 2.5万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 2.5万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 2.5万 - 项目类别: